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-activated K + (SK) channels are expressed widely in different tissues, including nervous system, vascular endothelium, skeletal muscle, smooth muscle, and cardiac myocytes. [1] [2] [3] SK channels are encoded by at least three genes: SK1, SK2, and SK3 (KCNN1, KCNN2, and KCNN3). 4 SK channels are characterized by their small unitary conductance (4-20 pS), sensitivity to submicromolar Ca 2+ , very weak voltage sensitivity, and selective blockade by apamin. [5] [6] [7] A recently described SK blocker, (R)-
N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593), acts by decreasing the Ca
2+ sensitivity of SK channels rather than blocking their pore. 8 
Clinical Perspective on p 440
After early interest in the function of Ca 2+ -dependent K + channels in the heart, skepticism about the evidence led to a consensus that they do not play a significant role. 9 Interest was rekindled by the work of the Chiamvimonvat laboratory, which provided data suggesting functionally significant atrial expression in mice. 10, 11 Evidence was also provided that shortterm atrial tachypacing (AT-P) of rabbit pulmonary veins (PVs) induces action potential (AP) abbreviation by enhancing SK2-channel trafficking to the membrane. 12 SK2-current density appears to be enhanced in atrial fibrillation (AF). 13 Recently, single-nucleotide polymorphisms in the KCNN3 gene have been implicated in AF risk.
14 NS8593 suppresses acetylcholine-induced AF in isolated rat and rabbit hearts, as well as with short-term rat AT-P in vivo. 15 Background-Recent evidence points to functional Ca 2+ -dependent K + (SK) channels in the heart that may govern atrial fibrillation (AF) risk, but the underlying mechanisms are unclear. This study addressed the role of SK channels in atrial repolarization and AF persistence in a canine AF model. Methods and Results-Electrophysiological variables were assessed in dogs subjected to atrial remodeling by 7-day atrial tachypacing (AT-P), as well as controls. Ionic currents and single-channel properties were measured in isolated canine atrial cardiomyocytes by patch clamp. NS8593, a putative selective SK blocker, suppressed SK current with an IC 50 of ≈5 μmol/L, without affecting Na
The present study was designed to assess the role of SK channels in atrial electrophysiology and AF with the use of a dog model. Specifically, we aimed to evaluate the following: (1) SK-channel expression and role in repolarization of canine left atrial (LA) and PV cardiomyocytes; (2) SK-channel function and expression changes in the AF-maintaining substrate induced by AT-P; and (3) the potential role of SK channels in maintaining AF in the clinically relevant canine AT-P model.
Methods
A summary of principal methods is provided here (for details, see online-only Data Supplement).
Animal Model
Animal care procedures were approved by the Animal Research Ethics Committee of the Montreal Heart Institute. A total of 75 adult mongrel dogs (22-30 kg) were studied, divided into control (n=43) and AT-P (n=32) groups.
To create AT-P dogs, atrioventricular block was created by radiofrequency ablation under ketamine (5.3 mg/kg IV)/diazepam (0.25 mg/kg IV)/1.5% isoflurane anesthesia. Unipolar pacing electrode leads were inserted into the right ventricular apex and right atrial (RA) appendage, to pace the right ventricle and RA at 80 and 400 bpm, respectively, for 1 week. Atrial effective refractory period (aERP) and mean AF duration were measured as described previously. 16 Hearts were then excised and immersed in oxygenated Tyrode's solution.
Open-chest electrophysiological studies were performed in 14 dogs (7 controls, 7 AT-P), premedicated with ketamine (5.3 mg/kg IV)/diazepam (0.25 mg/kg IV), and anesthetized with 1.5% isoflurane under mechanical ventilation. Teflon-coated stainless-steel electrodes were inserted into the left ventricle and left-atrial (LA) appendage for recording and stimulation. After baseline recordings, 5 mg/kg NS8593 was injected, and 5 mg · kg -1 · h -1 NS8593 was infused to produce stable electrophysiological effects. Recordings were then repeated. aERP was measured at basic cycle lengths (BCLs) of 200, 250, and 300 ms. Left ventricular ERP was measured at a BCL of 300 ms. ERP was the longest S1-S2 failing to capture, with 5-ms S1-S2 decrements. AF was induced by burst pacing at 50 Hz and 10 V. Mean AF duration was based on 10 AF inductions in each dog or 5 if the mean duration of the first 5 episodes of AF was longer than 2 minutes. The Wenckebach cycle length was measured as the longest RA BCL failing to conduct 1:1.
Cardiomyocyte Isolation
Single canine LA and PV cardiomyocytes were isolated with previously described methods. 17 Isolated cardiomyocytes were stored in 200 µmol/L Ca 2+ -containing Tyrode's solution for AP recording and in Kraftbruhe storage solution for current recording.
Cellular Electrophysiology
All in vitro recordings except for Na + current voltage-clamp and single-channel studies were obtained at 37°C. The whole-cell perforated-patch technique was used to record APs in current-clamp mode and tight-seal patch clamp to record currents in voltage-clamp mode. Borosilicate glass electrodes (Sutter Instruments, Novato, CA) filled with pipette solution had tip resistances of 2 to 4 mol/LΩ. For perforated-patch recording, nystatin-free intracellular solution was placed in the tip of the pipette, and then pipettes were backfilled with nystatin-containing (600 μg/mL) solution. Data were sampled at 5 kHz and filtered at 1 kHz. Whole-cell currents are expressed as densities (picoamperes per picofarads). Junction potentials averaged 10.5 mV and were corrected for APs only. For solution details, see online-only Data Supplement Methods. Cell capacitances averaged 90±3.5 and 89±2.9 pF (n=62 per group; P value is nonsignificant) in control LA and PV cells.
SK current was recorded using a voltage ramp from -110 to +70 mV from a holding potential of -55 mV (Figure 1 ), as described previously. 18 The extracellular solution for whole-cell SK-current recording contained the following (in mmol/L): 140 N-methylglucamine, 5. -free solutions until channel openings disappeared. If the channel openings did not disappear after 5 minutes (indicating non-SK channels), the recording was terminated. Open and closed levels were determined from all-point amplitude histograms (see Figure I in 
Quantitative Polymerase Chain Reaction
LA and PV cardiomyocytes were isolated by enzymatic digestion. Tissues were minced with scissors and then filtered on 100-µm mesh.
To separate cardiomyocytes from fibroblasts, the cells were centrifuged, and the pellet was resuspended 3 times in Kraftbruhe solution (2 minutes, 500 rpm), before a final centrifugation (2 minutes, 1000 rpm) with the cardiomyocyte-containing pellet flash frozen in liquid N 2 for subsequent RNA isolation. RNA was isolated with Nucleospin RNA-II (MachereyNagel), including deoxyribonuclease treatment to prevent genomic contamination. mRNAs were reverse transcribed with the High-Capacity Reverse Transcription kit (Applied Biosystems). Quantitative polymerase chain reaction was performed with TaqMan probes and primers from Applied Biosystems for SK1 (assay identification no. Cf02735889_mH), SK2, and SK3 (custom designed). Glucose-6-phosphate dehydrogenase (assay identification no. Cf02646196_m1) was used for normalization. Quantitative polymerase chain reaction reactions were performed with TaqMan Gene Expression Master Mix kit (Applied Biosystems) on a Stratagene MX3000. Standard curves were generated for each set of primers over a 2-log range. Relative gene expression values were calculated by the 2 -ΔCt method.
Western Blot
LA and PV cells were homogenized in radioimmunoprecipitation assay buffer as described previously. 19 The homogenate was centrifuged (15,000 rpm, 20 minutes, 4°C). The supernatant was used for protein concentration measurement by Bradford assay (BioRad, Mississauga, Ontario, Canada) with BSA as a standard. For 
Data Analysis
Clampfit 9.2 (Molecular Devices), GraphPad Prism 5.0, and Origin 5.0 were used for electrophysiological data handling and curve fitting. All data are expressed as mean±SEM. Data were analyzed statistically with repeated-measures mixed-effects model when the same set of units of analysis (dogs or cells) was exposed to multiple interventions. Depending on experimental design, multilevel models were chosen to take into account correlation between multiple levels of within-dog or within-cell measurements. When analyses were performed for multiple cells per dog, the unit used for analysis was the independent variable dog. When applicable, heterogeneity of variance was accounted for in the models. Multiple-group comparisons and individual group-mean differences were studied using main F tests of the models and specific contrasts with Bonferroni's correction, respectively. Adjusted P values were calculated by multiplying original P values by the number of comparisons (N) performed; values shown are adjusted values (NxP).
The N values used for correction are provided in the figure legends for all analyses. The statistical approach used for each dataset is provided in the figure legend. All study data satisfied a Kolmogorov-Smirnov test for normal distribution, except for AF durations, which were normally distributed after log transformation and were thus analyzed. All analyses were performed with SAS 9.3 (SAS Institute, Cary, NC). P<0.05 was considered to represent statistical significance. Figure 1A shows putative SK currents recorded with a ramp protocol at baseline (control) and after the addition of 10 μmol/L NS8593. The current reversed close to -75 mV (corrected for junction potential) and was strongly inhibited by NS8593. Drugsensitive current obtained by digital subtraction is shown in Figure 1B To confirm the selectivity of NS8593 effects in canine atrial myocytes, we recorded a variety of currents before and after exposure to 10 μmol/L NS8593. Figure 2A shows original Na + current recordings before and after exposure to NS8593, along with mean current-density/voltage data. Na + current density was similar before versus after the drug. Figure 2B shows original Ca 2+ current recordings before and after NS8593. As indicated in the mean data at the right, the current was unaffected by the compound. Figure 2C through 2F shows, respectively, current-density/voltage relations for transient outward, inward-rectifier, slow delayed-rectifier, and rapid delayed-rectifier K + currents during voltage steps according to the voltage protocols shown in the insets (delivered at 0.1 Hz). Examples of original recordings for each type of current are provided in Figure III in the online-only Data Supplement. We also sought to assess potential effects on the dog ultrarapid delayed rectifier current that we reported previously in canine atrial myocytes. 20 Despite significant effort, in the present experiments, we were unable to record any significant current of the type we reported previously. The ultrarapid delayed rectifier current and any analogous currents would contribute to the end-pulse steady-state current after transient outward current inactivation. 20, 21 Figure IVA and IVB in the online-only Data Supplement shows that NS8593 had no effect on transient outward and steady-state current-voltage relations. We also verified whether NS8593 might have differential effects on LA versus PV inward-rectifier current, and no such differences were seen (see Figure IVC and IVD in the online-only Data Supplement). In summary, NS8593 had no effect on any of the non-SK currents studied.
Results
Effects of NS8593 on Canine Atrial Ionic Currents
Single-Channel Properties and Effects of AT-P
Single-channel recordings of SK channels are shown in Figure 3 . SK Ca channels were characterized by their small conductance, sensitivity to Ca 2+ , and NS8593 inhibition. ( Figure 3D ). The same applies to single-channel current amplitude ( Figure 3C ). However, there were significant differences in single-channel P o ( Figure 3E ), which was greater in AT-P than control. Figure 3 shows that single SK-channel opening is enhanced by AT-P. We also examined the effect of AT-P on whole-cell NS8593-sensitive currents. Figure 4A shows whole-cell currents elicited with a ramp protocol before and after NS8593 in LA and PV cells from one control dog. Figure 4B shows corresponding currents from an AT-P dog that were larger (note the difference in current scale compared with Figure 4A) . Figure 4C and 4D shows mean data for whole-cell NS8593-sensitive currents as a function of voltage in LA and PV cells, respectively, for both control and AT-P dogs. Note that these currents were recorded with physiological transmembrane K + -concentration gradients, as for other K + currents, so the reversal potential is close (approximately -70 mV after adjusting for junction potential) to the physiological K + equilibrium potential. AT-P significantly increased current densities in both LA and PV cells. NS8593-sensitive current was significantly larger in PV versus LA cells: at -90 mV, -1.47±0.24 versus -0.58±0.10 pA/pF in controls (P<0.01) and -2.64±0.31 versus -1.20±0.13 pA/pF in AT-P (P<0.001).
Molecular Correlates
Our functional data indicate that SK current is larger in canine PV than LA and is upregulated by AT-P. The increased P o of SK channels in AT-P versus control ( Figure 3E ) could, at least partially, explain the increased SK current with AT-P. However, this possibility does not exclude the participation of additional factors, such as differential subunit expression, and the similar P o for PV versus LA indicates that kinetic factors cannot explain the PV-LA SK-current differences. To address a potential molecular basis at the level of channel expression differences, we quantified the 3 known SK subunits at mRNA and protein levels. Figure 5A shows mRNA expression results. Of the 3 subunits tested, KCNN2 (SK2) was the only differentially expressed subunit at the mRNA level, with stronger expression in PV than LA. Mean protein expression data are shown in Figure 5B , with corresponding original Western blots in Figure VI in the onlineonly Data Supplement. Unlike mRNA expression, SK1 protein expression was upregulated by AT-P in both PV and LA, without LA-PV differences. SK2 protein expression paralleled mRNA in being significantly stronger in PV versus LA. SK3 showed no significant expression differences between LA and PV or AT-P versus control. Overall, the expression data are in keeping with our functional findings but suggest a complex picture, with SK1 potentially contributing to AT-P versus control differences and 
Role in Repolarization and AF Substrate
To assess the potential functional importance of SK current in repolarization, we recorded APs from canine LA and PV cardiomyocytes and examined the effect of NS8593. Figure 6A through 6D shows AP recordings from each region/condition studied, before and after 10 μmol/L NS8593. The drug clearly prolonged AP duration (APD) for all but control LA conditions, indicating a significant role in repolarization. No statistically significant changes were seen in resting membrane potential or AP amplitude (see Figure VII in the online-only Data Supplement) with SK current block by NS8593.
In Vivo Effects of SK Current Inhibition
To test the potential role of SK current in AF maintenance, we administered NS8593 in vivo to control and AT-P dogs and studied resulting electrophysiological changes. NS8593 increased aERP, consistent with the AP changes that we noted. AT-P produced typical changes in aERP, with substantial aERP abbreviation and reversal of aERP abbreviation with increased rate (reduced BCL). NS8593 produced substantial aERP increases, which were greater in AT-P dogs (eg, 89.6±13.6% at BCL of 300 ms) than in control dogs (15.2±6.3%). Ventricular ERP ( Figure 7B ) was unaffected by AT-P or NS8593. Wenckebach cycle length (measurable only in control dogs because AT-P dogs had AV block) was not altered by NS8593 ( Figure 7C ). Blood pressure was similarly not significantly altered by the drug (Figure 7D) . AF responses are shown in Figure 8 . Control dogs had no AF induction during ERP testing, with similar results in the presence of NS8593. AT-P significantly increased the percentage of S2 stimuli that produced AF episodes, and NS8593 significantly reduced AF inducibility in AT-P dogs ( Figure 8A) . Figure 8B and 8C shows examples of AF induction by burst pacing in control and AT-P dogs, respectively, before and after NS8593. Mean AF duration was significantly reduced by NS8593, under both control and AT-P conditions ( Figure 8D ).
Discussion
In this study, we assessed the role of SK channels in atrial repolarization and AF vulnerability. Complementary pharmacological, biophysical, and molecular methods were used and demonstrated that SK current is present in canine atrium, has greater macroscopic density in PV than LA, and is upregulated at the level of both whole-cell current and single-channel P o by AF-related AT-P remodeling. Complex differences in SK-subunit mRNA and protein expression were noted, and in vivo studies pointed to roles for SK current in atrial repolarization, AF-related remodeling, and AF susceptibility.
SK Channels and Arrhythmias
SK channels are expressed in a wide variety of tissues, including nervous system, skeletal muscle, and smooth muscle, and play important roles in many physiological processes. 1, [22] [23] [24] [25] [26] [27] For quite a while, the evidence for a functional role of SK channels in the heart was considered questionable. 9 An elegant series of papers from the Chiamvimonvat laboratory restored interest in cardiac SK channels. They first demonstrated the presence of SK currents in human and mouse hearts and showed regional differences with atrial dominance, raising the possibility of atrial-selective therapeutic targeting. 10 They then cloned the 3 principal forms of SK subunits, SK1-SK3, from mouse hearts, confirming sequence homologies and atrial predominance of isoforms 1 and 2 and equal atrial/ventricular expression of SK3.
28 Ablation of SK2 channels in mice led to APD prolongation and atrial early afterdepolarization-related arrhythmia inducibility. 11 Ozgen et al 12 showed that short-term burst pacing of rabbit PVs reduced APD in a way that correlated with increases in apamin-sensitive current and increases in SK2 mRNA and protein expression. Li et al 13 subsequently showed increased SK current and SK2 protein expression in patients with persistent AF. The potentially important role of SK channels in AF has been highlighted by the finding that variants in the gene (KCNN3) encoding SK3 are significantly related to AF risk in man.
14 Recent studies have also pointed to important contributions of SK channels to ventricular repolarization and arrhythmogenesis in cardiac failure 29,30 and infarction.
31
Our studies advance the understanding of the role and mechanisms of SK-channel involvement in AF and atrial electrophysiology by providing a number of novel observations. We demonstrate PV-selective localization of SK currents and KCa2.2 subunits, which may contribute to the well-recognized but poorly understood role of the PVs in AF. 32 Conversely, we also noted upregulation of KCa2.1 subunit protein expression with AT-P. We also performed single-channel analyses of SK currents in cardiac tissue, which confirmed the biophysical properties of the channels. The increased P o that we observed with AT-P indicates that remodeling-induced increases in macroscopic currents do not arise solely from channel-subunit expression changes but that kinetic factors determining P o are also involved. Our work with blockers points to a contribution of SK channels to atrial repolarization, remodeling, and AF susceptibility in a clinically relevant paradigm of persistent AF-related atrial remodeling.
SK Current as a Pharmacological Target
Demonstration of atrial-selective expression of SK channels pointed to the potential interest of targeting them as an antiarrhythmic strategy with reduced risk of ventricular proarrhythmia. 10 ,28 NS8593 has been developed as a prototype membrane-permeable SK-channel blocker 8 that can be given in vivo as an AF-suppressing agent. The compound prolongs refractoriness and suppresses cholinergic AF in guinea pig and rabbit hearts. 15 It is also effective in acute burstpacing-induced AF in the rat, an action shared with 2 other SK-blocking compounds. 33 Additionally, NS8593 is effective in hypertensive rats with enhanced AF vulnerability. 34 The present study confirms the selectivity of NS8593 for SK channels, finding no effect on a broad range of other native K + channels, as well as native Na + and Ca 2+ currents. We also tested the drug for the first time in a large-animal model that presents a clinically relevant paradigm of AF-associated remodeling, finding significant efficacy in both refractoriness prolongation and suppression of AF vulnerability. The lack of effect on ventricular refractoriness and blood pressure is encouraging.
Several caveats must be recognized. The role of SK channels in ventricular rhythm control appears complex. SK-channel activation has been linked to ventricular arrhythmogenesis in acute myocardial infarction 31 and experimental heart failure, 29 suggesting that blocking SK channels could have useful ventricular antiarrhythmic actions. Conversely, SK-channel block causes frequency-dependent effects on the APD of failing rabbit ventricles, and blocking them can either promote arrhythmogenesis by impinging on repolarization reserve (predominant at long cycle lengths) or prevent arrhythmogenesis by flattening the slope of the APD-restitution curve. 30 Similarly, although in this study we demonstrate clear anti-AF effects in a clinically relevant dog model, consistent with a number of previous analyses, 15, 33, 34 loss of SK-channel function has been associated previously with AF-promoting early afterdepolarizations 11 and, more recently, SK block has been shown to favor the production of alternans, wavebreak, and atrial arrhythmias in isolated canine atrium. 35 Finally, it remains to be seen whether targeting of cardiac SK channels can be achieved without significant detrimental effects on other organ systems in which SK channels play important roles.
1,22-27
Potential Limitations
We used a specific model of AF in which to test the antiarrhythmic efficacy and atrial selectivity of NS8593. However, this is only one of several animal AF models, each of which reproduces some, but far from all, aspects of clinical AF pathophysiology. 32, 36 Because of the large density of SK single channels in canine atrium, we were unable to obtain patches containing only 1 channel and were therefore unable to analyze precisely regional-or remodeling-dependent differences in channel kinetics (mean closed or open time values).
We attempted to record ultrarapid delayed rectifier current in the present study and indeed in several other experimental series over the past 10 years and were unsuccessful. This differs from our experience in the 1990s, 20 when we first reported this current in dog atrium and routinely saw robust currents. We are not sure whether the difference relates to differences in collagenase lot availability, subtle changes in isolation technique, or the animals available. Other investigators have reported Kv1.5-type currents in canine atrium, 21 which we are similarly unable to find. We can only assume that such currents are variously expressed or sensitive to unidentified technical details.
Our results regarding the effects of atrial-tachycardia remodeling on SK currents differ from those of a previous study that found downregulation of SK current and proteins in atrial samples from AF patients. 37 These discrepancies may reflect species-dependent differences, effects of underlying heart disease in AF patients, or other presently unidentified factors.
The principal probe that we used to study Ca 2+ -dependent K + current was NS8593, and no pharmacological compound is perfectly specific for the target of interest. NS8593 is part of a series of compounds that inhibit SK currents by negative gating modulation, which results in a shift of the Ca 2+ concentration-response curve toward higher Ca 2+ concentrations (ie, reducing affinity of the channel for Ca 2+ ).
38 Although the mechanism is presumed to be quite selective and we showed experimentally high selectivity of NS8593 for SK In these experiments, we did not see a statistically significant difference in resting membrane potentials among the different cell populations and conditions (see Figure VII in the onlineonly Data Supplement), although based on previous results in the literature, we might have expected PV cells to be less polarized than LA 39 and AT-P cells to be hyperpolarized relative to control 40 because of differences in inward-rectifier current.
39-41
Resting potential differences under these conditions are relatively small 39,40 and may have been masked by intercell variability, particularly because inward-rectifier current is very sensitive to cell isolation. In addition, in the present study, we isolated PV cells from the main body of the PV cardiomyocyte sleeve rather than as distally as possible in previous work. 39 Changes in resting potential can have important effects on AF stability 42 and could be significantly modulated by a nonvoltage-gated K + conductance like that of SK channels. In view of the acute ratedependent atrial-cell Ca 2+ load resulting from AF, 17 ,32 SK current would be expected to increase and might cause substantial hyperpolarization. The issue of resting-potential changes and how they are influenced by SK-channel function and remodeling is therefore an important area to consider in future studies.
Conclusions
In the present study, we have shown the following: (1) that SK2 subunit expression and SK current are greater in canine PV versus LA; (2) that AT-P increases SK1 protein expression, SK-channel P o , and SK current; and (3) that an SK-current blocker increases atrial APD and ERP, while showing clear in vivo anti-AF effects. These results are relevant to the potential mechanisms underlying the association between SK Ca singlenucleotide polymorphisms and AF and support the possibility that SK blockers may be potentially interesting anti-AF drugs. January 28, 2014 
CLINICAL PERSPECTIVE
There is increasing evidence for a role of calcium-dependent potassium (SK) channels in cardiac electrophysiology, including gene-wide association studies showing that variants of a calcium-dependent potassium-channel gene (KCNN3) are an important risk factor for atrial fibrillation (AF) in man. In this study, we examined the role of SK channels in the electrophysiological properties of canine atrial tissue. We used patch-clamp methods to record whole-cell and single-channel SK currents from dog left atrial (LA) and pulmonary vein (PV) cells, in both normal dogs and dogs subjected to 1 week of rapid atrial pacing to mimic AF. In addition, we exploited a selective SK channel channel blocker (NS8593) to study the functional role of the channel. Measurable whole-cell SK current was detected in dog atrial cells, larger in PV than LA. In addition, atrial tachypacing enhanced SK-current amplitude. Consistent with the ion-current data, blocking SK channels prolonged atrial repolarization, with larger changes in PV than LA and larger increases in cells from tachypaced dogs than normal dogs. Single-channel open probability was enhanced by atrial tachypacing but was not significantly different in PV versus LA. Measurements of SK-channel subunit protein expression showed differences consistent with the relative ion-current differences between PV and LA and between tachypacing and control. In vivo SK-channel block with NS8593 prolonged refractoriness and suppressed AF, implying that SK channels are involved in atrial repolarization and contribute to the control of AF sustainability. These findings suggest that SK-channel gene variants may modulate the risk of AF by altering atrial repolarization and that SK-channel blockers might be an interesting target for AF-suppressing therapy.
SUPPLEMENTAL MATERIAL Detailed Methods
Animal Model
All animal care procedures followed Canadian Council on Animal Care and National
Institutes of Health guidelines and were approved by the Animal Research Ethics
Committee of the Montreal Heart Institute. A total of 71 adult mongrel dogs (22-30 kg)
were studied, divided into control (n=43) and AT-P (n=32) groups.
To create AT-P dogs, atrioventricular block was created by radiofrequency ablation Open-chest electrophysiological studies to study the in vivo effects of NS8593 were performed in 14 dogs (7 controls and 7 AT-P). Dogs were premedicated with ketamine to the ventricles) was measured to evaluate effects on AV-nodal properties. Blood pressure and heart rate were monitored
Cardiomyocyte Isolation
For in vitro study, dogs were anesthetized as described above, euthanized by cardiac excision, and atrial tissue taken for cell-isolation. Single canine LA and pulmonary-vein (PV)-cells were isolated with previously-described methods. 
Quantitative Polymerase Chain Reaction (qPCR)
LA and PV cardiomyocytes were isolated by enzymatic digestion. Tissues were minced with scissors and then filtered on 100 µm mesh. To separate cardiomyocytes from fibroblasts, the cells were centrifuged and the pellet resuspended 3 times in KB (2 minutes, 500 rpm), before a final centrifugation (2 minutes, 1000 rpm) with the cardiomyocyte-containing pellet flash-frozen in liquid-N 2 for subsequent RNA-isolation.
RNAs was isolated with Nucleospin RNA-II (Macherey Nagel), including DNasetreatment to prevent genomic contamination. Messenger RNAs were reverse-transcribed with the High-capacity Reverse Transcription kit (Applied Biosystems). Quantitative PCR was performed with TaqMan probes and primers from Applied Biosystems for SK1 (Assay ID: Cf02735889_mH), SK2 and SK3 (custom-designed). G6PD (Assay ID: Cf02646196_m1) was used for normalization. Quantitative PCR reactions were performed with Taqman Gene Expression Master Mix kit (Applied Biosystems) on a Stratagene MX3000. Standard curves were generated for each set of primers over a 2-log range. Relative gene-expression values were calculated by the 2 -ΔCt method.
Western Blot
LA and PV cells were homogenized in RadioImmuno Precipitation Assay (RIPA) buffer as previously described. 5 The homogenate was centrifuged (15, Data were analyzed statistically with repeated-measures mixed effects model when the same set of units of analysis (dogs or cells) was exposed to multiple interventions. Depending on experimental design, multi-level models were chosen to take into account correlation between multiple levels of within-dog and/or within-cell measurements. When analyses were performed for multiple cells per dog, the unit used for analysis was the independent variable dog. When applicable, heterogeneity of variance was accounted for in the models. Multiple-group comparisons and individual group-mean differences were studied using respectively main F-tests of the models and specific contrasts with Bonferroni correction. legends for all analyses. The statistical approach used for each data set is now provided in the figure legend. All study data satisfied a Kolmogorov-Smirnov test for normal distribution, except for AF durations, which were normally distributed after logtransformation and were thus analyzed. All analyses were performed with SAS 9.3 (SAS Institute, Cary, North Carolina).
